Feedback / Questions
zabalafin hydrogel (AB-101a) - Alphyn Biologics
https://www.prnewswire.co.uk/news-releases/alphyn-doses-first-patients-in-clear-ad1-global-phase-2b-clinical-trial-program-for-atopic-dermatitis-302451756.html
May 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next